Literature DB >> 16099800

Use of psychopharmacological agents for functional gastrointestinal disorders.

R E Clouse1, P J Lustman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099800      PMCID: PMC3260562          DOI: 10.1136/gut.2004.048884

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  63 in total

Review 1.  AGA technical review on irritable bowel syndrome.

Authors:  Douglas A Drossman; Michael Camilleri; Emeran A Mayer; William E Whitehead
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

2.  Antidepressants and chronic pain.

Authors:  H J McQuay; R A Moore
Journal:  BMJ       Date:  1997-03-15

3.  Symptoms of major depression and tricyclic side effects in primary care patients.

Authors:  B L Rollman; M R Block; H C Schulberg
Journal:  J Gen Intern Med       Date:  1997-05       Impact factor: 5.128

Review 4.  Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials.

Authors:  J Jailwala; T F Imperiale; K Kroenke
Journal:  Ann Intern Med       Date:  2000-07-18       Impact factor: 25.391

Review 5.  A review of the evidence for overlap among unexplained clinical conditions.

Authors:  L A Aaron; D Buchwald
Journal:  Ann Intern Med       Date:  2001-05-01       Impact factor: 25.391

6.  Duloxetine in the long-term treatment of major depressive disorder.

Authors:  Joel Raskin; David J Goldstein; Craig H Mallinckrodt; Margaret B Ferguson
Journal:  J Clin Psychiatry       Date:  2003-10       Impact factor: 4.384

Review 7.  The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder.

Authors:  A J Gruber; J I Hudson; H G Pope
Journal:  Psychiatr Clin North Am       Date:  1996-06

8.  The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome.

Authors:  Francis Creed; Lakshmi Fernandes; Elspeth Guthrie; Stephen Palmer; Joy Ratcliffe; Nicholas Read; Christine Rigby; David Thompson; Barbara Tomenson
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

9.  Paroxetine to treat irritable bowel syndrome not responding to high-fiber diet: a double-blind, placebo-controlled trial.

Authors:  Gary Tabas; Mary Beaves; Jiping Wang; Paul Friday; Houssam Mardini; George Arnold
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

Review 10.  Antidepressant discontinuation syndromes.

Authors:  P M Haddad
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

View more
  24 in total

Review 1.  Management of the patient with incomplete response to PPI therapy.

Authors:  Peter J Kahrilas; Guy Boeckxstaens; Andre J P M Smout
Journal:  Best Pract Res Clin Gastroenterol       Date:  2013-06       Impact factor: 3.043

Review 2.  How do SSRIs help patients with irritable bowel syndrome?

Authors:  F Creed
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

Review 3.  Irritable bowel syndrome: diagnosis and management.

Authors:  A Agrawal; P J Whorwell
Journal:  BMJ       Date:  2006-02-04

Review 4.  Clinical practice. Irritable bowel syndrome.

Authors:  Emeran A Mayer
Journal:  N Engl J Med       Date:  2008-04-17       Impact factor: 91.245

5.  Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial.

Authors:  Ernest P Bouras; Nicholas J Talley; Michael Camilleri; Duane D Burton; Michael G Heckman; Julia E Crook; Elliott Richelson
Journal:  Am J Gastroenterol       Date:  2008-08       Impact factor: 10.864

6.  Increased risk of osteoporosis-related fractures in patients with irritable bowel syndrome.

Authors:  D J Stobaugh; P Deepak; E D Ehrenpreis
Journal:  Osteoporos Int       Date:  2012-09-20       Impact factor: 4.507

Review 7.  Treatment of abdominal pain in irritable bowel syndrome.

Authors:  Tim Vanuytsel; Jan F Tack; Guy E Boeckxstaens
Journal:  J Gastroenterol       Date:  2014-05-21       Impact factor: 7.527

8.  Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease.

Authors:  Heba N Iskandar; Benjamin Cassell; Navya Kanuri; C Prakash Gyawali; Alexandra Gutierrez; Themistocles Dassopoulos; Matthew A Ciorba; Gregory S Sayuk
Journal:  J Clin Gastroenterol       Date:  2014 May-Jun       Impact factor: 3.062

9.  Tricyclic antidepressants for chronic vomiting in diabetic patients.

Authors:  Mandeep S Sawhney; Chandra Prakash; Patrick J Lustman; Ray E Clouse
Journal:  Dig Dis Sci       Date:  2006-12-30       Impact factor: 3.199

Review 10.  Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment.

Authors:  Carol S North; Barry A Hong; David H Alpers
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.